Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Dexcom Inc shares valued at $45,347 were sold by Brown Michael Jon on Jul 31 ’24. At $69.55 per share, Brown Michael Jon sold 652 shares. The insider’s holdings dropped to 66,249 shares worth approximately $4.79 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, MICHAEL BROWN purchased 652 shares, netting a total of over 45,347 in proceeds.
Before that, Brown Michael Jon had sold 659 shares from its account. In a trade valued at $75,317, the EVP Chief Legal Officer traded Dexcom Inc shares for $114.29 each. Upon closing the transaction, the insider’s holdings decreased to 659 shares, worth approximately $4.84 million.
As published in a research note from Robert W. Baird on July 26, 2024, Dexcom Inc [DXCM] has been rated down from an Outperform to a Neutral and the price target has been revised to $80 from $161. Analysts at JP Morgan downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in late July. As of May 30, 2024, Redburn Atlantic has initiated its “Neutral” rating for DXCM. Earlier on March 12, 2024, RBC Capital Mkts initiated its rating. Their recommendation was “an Outperform” for DXCM stock.
Analyzing DXCM Stock Performance
During the last five days, there has been a drop of approximately -0.11%. Over the course of the year, Dexcom Inc shares have dropped approximately -41.75%. Shares of the company reached a 52-week high of $142.00 on 03/26/24 and a 52-week low of $62.34 on 07/26/24. A 50-day SMA is recorded $96.37, while a 200-day SMA reached $116.85. Nevertheless, trading volume fell to 3.57 million shares from 7.58 million shares the previous day.
Support And Resistance Levels for Dexcom Inc (DXCM)
According to the 24-hour chart, there is a support level at 71.45, which, if violated, would cause prices to drop to 70.63. In the upper region, resistance lies at 73.83. The next price resistance is at 75.39. RSI (Relative Strength Index) is 37.01 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.37, which suggests the price will decrease in the coming days. Percent R is at 61.27%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
